Anagrelide treatment and cardiovascular monitoring in essential thrombocythemia. A prospective observational study

This publication has 21 references indexed in Scilit:

• Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
  Blood, 2012
• A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
  Blood, 2012
• Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
  Journal of Clinical Oncology, 2011
• Guideline for investigation and management of adults and children presenting with a thrombocytosis
  British Journal of Haematology, 2010
• Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
  Leukemia, 2007
• Risk Factors for Thrombosis and Bleeding and Their Influence on Therapeutic Decisions in Patients with Essential Thrombocythemia
  Seminars in Thrombosis and Hemostasis, 2006
• Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients
  Leukemia, 1999
• Acute coronary disease in essential thrombocythemia and polycythemia vera
  Journal of Internal Medicine, 1998
• Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors
  British Journal of Haematology, 1993
• Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.
  Journal of Clinical Oncology, 1990